Clinical Trial Update: A Controlled Human Rhinovirus Infection Study of 2-Deoxy-D-Glucose in Healthy Adults [Phase 2]

View source ↗

Summary

Phase 2 controlled human rhinovirus infection study evaluating 2-Deoxy-D-glucose in healthy adults was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngitis

Drugs mentioned

• 2-Deoxy-D-glucose (2-Deoxy-D-glucose)

Snippet

Sponsor: G.ST Antivirals GmbH | Conditions: Acute Nasopharyngitis | Phase 2 | Status: TERMINATED